Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Infusion Pumps: Technology and Market 2012-2022
Market Study
Published: February 2012
Pages: 140
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1699.00 Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Drug Delivery
Infusion Pumps: Technology and Market 2012-2022 report forecasts the size and value of leading national/regional markets: North America, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period. The use of infusion pumps is still more prevalent in the developed regions of North America and Europe, essentially owing to the fact that the infusion pump technology is expensive when compared to the competing technologies. The cost of insulin pumps is covered under Medicare in the US and through private insurance in Canada. However, there are huge opportunities for infusion pump manufacturers in the developing economies of India and China where the use of electronic infusion pumps is limited at present. The report discusses the future technological development that will make the infusion pumps more attractive to the patients and drive their adoption.
Infusion Pumps: Technology and Market 2012-2022 also examines the challenges facing the sector critically, including the high cost and safety issues. The report is developed through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses and a review of companies and leading products.
Why you should buy Infusion Pumps: Technology and Market 2012-2022
In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for infusion pumps, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall infusion pumps market from 2011 to 2022 - seeing where commercial growth will occur
• You will discover sales trends for the main segments - insulin pumps and enteral feeding pumps - from 2011 to 2022, with detailed discussions of market potential
• You will receive sales forecasts for leading national/regional markets (North America, Japan, Europe, India and China), with informed discussion
• You will assess leading manufacturers and products in the leading segments of the infusion pumps market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the infusion pumps market from 2012 onwards
• You will be able to investigate competition and opportunities influencing the infusion pumps technology for drug delivery from 2012 onwards
• You will see what will stimulate and restrain the market from 2012
• You will discover the unmet needs in the market, driving the growth from 2012 onwards.
You can order this report today
Anybody with an interest in the infusion pumps market should gain valuable information and insight from this new study by Visiongain, which analyses one of the most important sub-sectors of the drug delivery industry. The infusion pumps market is undergoing many important shifts. You can stay ahead by ordering this report today.
Companies Listed
Abbott Laboratories
Abbott Nutrition
AcelRX
Acura Pharmaceuticals
Alcare Inc
ALCOR Scientific
Alkemes
Animas Corporation
Aradigm
ART Healthcare
Asante Solution
AstraZeneca
B.Braun
Baxter
BioDelivery Sciences
Boston University
Calibra Medical
Cambridge University
Cardinal Health
CareFusion Corporation
Celegene
Cellnovo
Center for Devices and Radiological Health (CDRH)
CeQur
China Aoxing
Codman & Shurtleff Inc
Covidien
D Medical Industries
Danone
Debiotech
DePuy
Diagnostic Systems
Disetronic
Dorn Veterans Administration Medical Center
DURECT
Eli Lilly
Emisphere
FDA
FDA MedWatch
Fresenius Kabi
Generex Biotechnology Corporation
GlaxoSmithKline (GSK)
Glycologic
Hospira
IBM
Insulet
Intercell
Johnson and Johnson (J&J)
Juvenile Diabetes Research Foundation (JDRF)
King Pharmaceuticals
MEDINGO Ltd
Medtronic
Micrus Endovascular
Moog
Nestle Healthcare
NiliMEDIX
Nipro Diagnostics
Novartis
Noven Pharmaceuticals
Novo Nordisk
Nutricia
Oregon Health & Science University
OST Medical
Pacira Pharmaceuticals
Pain Therapeutics
PAION
Pfizer
Pharmaco-Kinesis Corporation
pSivida Corporation
Purdue Pharma
Q Core Medical
QRx Pharmaceuticals
Roche
Roche Diagnostics
Sanofi-Aventis
Sansum Diabetes Research Institute
Shire Pharmaceuticals
SIGMA Spectrum
Smith Group Plc
Smith Medical
SOOIL
Spring
ST Microelectronics
Stanford University
Summit Medical Products
Takeda
Tandem Diabetes Care
Titan Pharmaceuticals
Valeritas
Vectura
WalkMed Infusion

